Pfizer infringed haemophilia therapy patent, says court

UK High Court judge unconvinced by Pfizer that uniQure’s patent is invalid | Companies in dispute over patents covering haemophilia B therapies in the US, Canada and UK.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Big Pharma counsel embrace AI but data and legal risks loom

24 October 2024 Counsel from Pfizer, Gilead, and Bristol Myers Squibb spoke on AI’s transformative power and risks, reports Marisa Woutersen at LSPN Fall North America.

Europe

Pfizer and BioNTech win UK COVID-19 dispute

10 October 2024 Duo successfully invalidate two CureVac patents in the UK | High Court deems patents invalid due to lack of inventive step and insufficient technical contribution | CureVac “disappointed” but stressed outcome does not affect ongoing litigation in Germany and US.

More on this story

Americas

Big Pharma counsel embrace AI but data and legal risks loom

24 October 2024 Counsel from Pfizer, Gilead, and Bristol Myers Squibb spoke on AI’s transformative power and risks, reports Marisa Woutersen at LSPN Fall North America.

Europe

Pfizer and BioNTech win UK COVID-19 dispute

More on this story

Americas

Big Pharma counsel embrace AI but data and legal risks loom

24 October 2024 Counsel from Pfizer, Gilead, and Bristol Myers Squibb spoke on AI’s transformative power and risks, reports Marisa Woutersen at LSPN Fall North America.

Europe

Pfizer and BioNTech win UK COVID-19 dispute